205 related articles for article (PubMed ID: 12011795)
1. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
Prasko J; Horacek J; Klaschka J; Kosova J; Ondrackova I; Sipek J
Neuro Endocrinol Lett; 2002 Apr; 23(2):109-13. PubMed ID: 12011795
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder].
Güdücü F; Caliyurt O; Vardar E; Tuğlu C; Abay E
Turk Psikiyatri Derg; 2005; 16(4):245-51. PubMed ID: 16362843
[TBL] [Abstract][Full Text] [Related]
3. Adjunctive bright light in non-seasonal major depression.
Martiny K
Acta Psychiatr Scand Suppl; 2004; (425):7-28. PubMed ID: 15527426
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
Martiny K; Lunde M; Undén M; Dam H; Bech P
Acta Psychiatr Scand; 2005 Aug; 112(2):117-25. PubMed ID: 15992393
[TBL] [Abstract][Full Text] [Related]
5. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
[TBL] [Abstract][Full Text] [Related]
6. The lack of sustained effect of bright light, after discontinuation, in non-seasonal major depression.
Martiny K; Lunde M; Undén M; Dam H; Bech P
Psychol Med; 2006 Sep; 36(9):1247-52. PubMed ID: 16756691
[TBL] [Abstract][Full Text] [Related]
7. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal.
Bernstein GA; Borchardt CM; Perwien AR; Crosby RD; Kushner MG; Thuras PD; Last CG
J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):276-83. PubMed ID: 10714046
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.
Wirz-Justice A; Bader A; Frisch U; Stieglitz RD; Alder J; Bitzer J; Hösli I; Jazbec S; Benedetti F; Terman M; Wisner KL; Riecher-Rössler A
J Clin Psychiatry; 2011 Jul; 72(7):986-93. PubMed ID: 21535997
[TBL] [Abstract][Full Text] [Related]
10. Bright light augments antidepressant effects of medication and wake therapy.
Loving RT; Kripke DF; Shuchter SR
Depress Anxiety; 2002; 16(1):1-3. PubMed ID: 12203667
[TBL] [Abstract][Full Text] [Related]
11. Effect of bright white light on non-seasonal depressive disorder.
Mackert A; Volz HP; Stieglitz RD; Müller-Oerlinghausen B
Pharmacopsychiatry; 1990 May; 23(3):151-4. PubMed ID: 2374772
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of milnacipran and imipramine in the treatment of major depressive disorder.
Lopez-Ibor JJ; Conesa A;
Curr Med Res Opin; 2004 Jun; 20(6):855-60. PubMed ID: 15200743
[TBL] [Abstract][Full Text] [Related]
13. Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms.
Strong RE; Marchant BK; Reimherr FW; Williams E; Soni P; Mestas R
Depress Anxiety; 2009; 26(3):273-8. PubMed ID: 19016463
[TBL] [Abstract][Full Text] [Related]
14. [Sleep deprivation as a predictor of response to light therapy in major depression].
Heller R; Fritzsche M; Hill H; Kick H
Fortschr Neurol Psychiatr; 2001 Apr; 69(4):156-63. PubMed ID: 11386120
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of the efficacy of bright-light exposure and aerobic exercise on depressive symptoms and serum lipids.
Leppämäki SJ; Partonen TT; Hurme J; Haukka JK; Lönnqvist JK
J Clin Psychiatry; 2002 Apr; 63(4):316-21. PubMed ID: 12000205
[TBL] [Abstract][Full Text] [Related]
19. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
20. [Platelet serotonin transport in the group of outpatients with seasonal affective disorder before and after light treatment, and in remission (in the summer)].
Swiecicki L; Bidziński A; Tonderska A
Psychiatr Pol; 2005; 39(3):459-68. PubMed ID: 16149756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
